ea0010s22 | Evolving aspects in the HPA axis | SFE2005
ea0026s15.2 | Emerging therapies in type 2 diabetes | ECE2011
Stewart P , Cooper M , Lavery G , Tomlinson J
ea0019oc19 | Cardiovascular metabolism | SFEBES2009
Gathercole L , Buljalska I , Stewart P , Tomlinson J
ea0011p584 | Neuroendocrinology and behaviour | ECE2006
Agha A , Tomlinson J , Clark PM , Holder G , Stewart PM
ea0009oc3 | Oral Communication 1: Diabetes and metabolism | BES2005
Gathercole L , Bujalska I , Stewart P , Tomlinson J
ea0009p15 | Diabetes and metabolism | BES2005
Quinkler M , Bujalska I , Tomlinson J , Smith D , Stewart P
ea0007p219 | Steroids | BES2004
Bujalska I , Tomlinson J , Draper N , Walker E , Stewart P
ea0005oc23 | Obesity and Diabetes | BES2003
Tomlinson J , Shakespeare L , Holder G , Clark P , Stewart P
ea0005p216 | Steroids | BES2003
Tomlinson J , Bujalska I , Collard M , Stewart P
ea0003oc38 | Hormone Action | BES2002
Sinha B , Tomlinson J , Bujalska I , Hewison M , Stewart P